Interleukin-1beta and TNF-alpha: reliable targets for protective therapies in Parkinson´s Disease?
Neuroinflammation has received increased attention as a target for putative neuroprotective therapies in Parkinson´s Disease (PD). Two prototypic pro-inflammatory cytokines Interleukin-1beta (IL-1) and Tumor necrosis factor-alpha (TNF) have been implicated as main effectors of the functiona...
Main Authors: | María Celeste Leal, Juan Cruz Casabona, Mariana ePuntel, FERNANDO ePITOSSI |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-04-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fncel.2013.00053/full |
Similar Items
-
Serum interleukin-1beta and tumor necrosis factor-alpha in febrile seizures: is there a link?
by: Abolfazl Mahyar, et al.
Published: (2014-10-01) -
Features of alpha-synuclein that could explain the progression and irreversibility of Parkinson's disease
by: Scarlet eGallegos, et al.
Published: (2015-03-01) -
New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
by: Guoxin Zhang, et al.
Published: (2018-11-01) -
The Prion-Like Spreading of Alpha-Synuclein in Parkinson’s Disease: Update on Models and Hypotheses
by: Asad Jan, et al.
Published: (2021-08-01) -
Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
by: Thuy Thi Lai, et al.
Published: (2021-10-01)